NEW YORK CITY, NY – When biotech and pharmaceutical companies in America’s biotech powerhouse need specialized preclinical contract research organization (CRO) services, Anilocus delivers cutting-edge solutions that drive drug discovery forward. Providing preclinical CRO services to research teams located in the heart of New York’s thriving life sciences ecosystem, we provide comprehensive preclinical research support with the local accessibility and regulatory expertise your projects demand.
Your Local CRO Partner in America’s Biotech Powerhouse
New York City has established itself as a rapidly growing biotechnology hub, with the city creating LifeSci NYC – a $1.1 billion commitment to establish New York City as a global leader in life sciences, resulting in almost 20,000 jobs, over 500 R&D stage companies, and 3.5 million square feet of commercial life sciences space. The Alexandria Center for Life Science serves as the flagship location for New York City’s expanding life sciences sector, with over 1 million square feet of commercial laboratory space strategically located along Manhattan’s East Side Medical Corridor between Bellevue Hospital and NYU Medical Center.
The New York region hosts major pharmaceutical giants including Pfizer, headquartered in Manhattan, Regeneron Pharmaceuticals based in Tarrytown, and houses significant operations from Roche and Eli Lilly at the Alexandria Center. Innovative biotech companies are developing breakthrough therapies and technologies, all requiring specialized preclinical services to advance their drug development programs.
Why New York Biotech Choose Anilocus
- Collaborative network access – Established partnerships and working relationships with New York’s leading research institutions, enabling seamless knowledge transfer, shared expertise, and access to specialized equipment and core facilities
- Specialized in vivo capabilities – Advanced in vivo assessments and expertise that complement safety and efficacy therapeutics testing
- Integrated preclinical solutions – Comprehensive study design through regulatory submission support, reducing vendor management complexity and accelerating development timelines
CRO Excellence in the Big Apple
Anilocus specializes in preclinical research solutions that meet the demanding standards of New York’s pharmaceutical industry. Our capabilities span in vivo studies, behavioral neuroscience, advanced bioanalytics, and regulatory-compliant study execution. What sets us apart is our unique combination of scientific precision and custom fabrication capabilities, delivering exactly what your research requires in a city that never sleeps.
Operating in New York means being at the forefront of interdisciplinary research, where AI and machine learning are transforming life sciences, and where projects like the CZ Biohub New York collaboration with Columbia, Rockefeller, and Yale are harnessing the immune system to bring novel diagnostics and therapeutics to patients. Our preclinical studies are designed with this innovative environment in mind, ensuring seamless integration with New York’s cutting-edge research ecosystem.
With New York’s historic $150 million state investment in the New York BioGenesis Park, the largest nationwide investment for a cell and gene therapy hub, the region is rapidly becoming the leading global destination for CGT innovation. Anilocus is perfectly positioned to support this growth with specialized preclinical services that bridge the gap between laboratory discoveries and clinical applications.
Ready to Accelerate Your Research?
Ready to advance your preclinical research with a CRO partner that understands the unique demands and rapid pace of New York’s biotech ecosystem? From the towering research centers of Manhattan to the emerging biotech clusters in Long Island City and Brooklyn, Anilocus delivers the scientific excellence that New York companies demand.
Get Started Today!
Transform your research vision into actionable data with Anilocus, where scientific precision meets fabrication capability for real research impact in America’s most dynamic biotech hub. Contact us today and speak to a scientist!
